Edition:
United States

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

75.23USD
16 Feb 2018
Change (% chg)

$1.16 (+1.57%)
Prev Close
$74.07
Open
$74.51
Day's High
$75.63
Day's Low
$74.19
Volume
1,277,953
Avg. Vol
1,537,697
52-wk High
$83.49
52-wk Low
$55.80

Latest Key Developments (Source: Significant Developments)

Express Scripts Canada Awarded Health Canada Contract
Thursday, 1 Feb 2018 07:30am EST 

Feb 1 (Reuters) - Express Scripts Inc [RIC:RIC:EXPR.UL]::EXPRESS SCRIPTS CANADA AWARDED HEALTH CANADA CONTRACT.EXPRESS SCRIPTS CANADA SAYS FIVE-YEAR CONTRACT INCLUDES RENEWAL OPTIONS THAT CAN TOTAL UP TO 11 YEARS.  Full Article

Express Scripts Holding Sees FY 2017 ADJ SHR $7.00 To $7.08
Thursday, 14 Dec 2017 07:30am EST 

Dec 14 (Reuters) - Express Scripts Holding Co ::EXPRESS SCRIPTS HOLDING COMPANY UPDATES 2017 FULL-YEAR GUIDANCE AND ANNOUNCES 2018 FINANCIAL GUIDANCE.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $7.67 TO $7.87.SEES FY 2017 ADJUSTED EARNINGS PER SHARE $7.00 TO $7.08.EXPECTS 2017 FULL-YEAR TOTAL ADJUSTED CLAIMS FOR ITS CORE BUSINESS TO BE IN RANGE OF 1,158 MILLION TO 1,172 MILLION.NARROWED PREVIOUSLY ISSUED CONSOLIDATED 2017 ADJUSTED EBITDA GUIDANCE TO A RANGE OF $7,370 MILLION TO $7,450 MILLION.ESTIMATE THAT EVICORE ACQUISITION WILL GENERATE EBITDA OF $265 MILLION TO $285 MILLION IN 2018.EVICORE ACQUISITION AND SALE OF UNITED BIOSOURCE ARE EXPECTED TO BE COMPLETED IN DECEMBER 2017.ENTERPRISE VALUE INITIATIVE ESTIMATED TO COST ABOUT $600-$650 MILLION & TO DELIVER CUMULATIVE SAVINGS OF NEARLY $1.2 BILLION BY 2021.FY2017 EARNINGS PER SHARE VIEW $7.01 -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $7.65 -- THOMSON REUTERS I/B/E/S.SEES CORE ESTIMATED REVENUE FOR 2018 OF $80,500 MILLION TO $83,000 MILLION.SEES CONSOLIDATED ESTIMATED REVENUE FOR 2018 OF $99,000 MILLION TO $102,000 MILLION.FY2018 REVENUE VIEW $101.29 BILLION -- THOMSON REUTERS I/B/E/S.COMPANY EXPECTS CORE 2017 FULL-YEAR ADJUSTED EBITDA GUIDANCE IN RANGE OF $4,910 MILLION TO $4,970 MILLION.SEES CORE ESTIMATED TOTAL ADJUSTED CLAIMS FOR 2018 OF 1,125 MILLION TO 1,165 MILLION.SEES CONSOLIDATED ESTIMATED TOTAL ADJUSTED CLAIMS FOR 2018 OF 1,345 MILLION TO 1,395 MILLION.  Full Article

Avista Capital Partners To Acquire Express Scripts' Subsidiary United Biosource
Monday, 27 Nov 2017 09:15am EST 

Nov 27 (Reuters) - Express Scripts Holding Co ::AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE.AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE.EXPRESS SCRIPTS HOLDING CO - ‍AVISTA SIGNED DEFINITIVE AGREEMENT TO ACQUIRE UNITED BIOSOURCE, A SUBSIDIARY OF CO.  Full Article

Express Scripts appoints James Havel as CFO
Tuesday, 24 Oct 2017 04:07pm EDT 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts Holding Co appoints James M. Havel chief financial officer.Express Scripts Holding Co - ‍Eric Slusser, executive vice president and chief financial officer, is leaving company​.  Full Article

Express Scripts reports Q3 GAAP earnings per share $1.46
Tuesday, 24 Oct 2017 04:01pm EDT 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts announces 2017 third quarter results.Q3 adjusted earnings per share $1.90.Q3 GAAP earnings per share $1.46.Q3 earnings per share view $1.90 -- Thomson Reuters I/B/E/S.Sees Q4 2017 adjusted earnings per share $2.03 to $2.11.Express Scripts holding co qtrly ‍adjusted claims of 343.6 million, down 1 pct​.Qtrly ‍revenues $24,683 million versus $25,410 million.Express Scripts holding-‍increasing expected 2018 retention rate for 2017 selling season, excluding impact of remaining coventry business to be above 95 percent​.Says ‍company expects to formalize plan for its enterprise value initiative by end of 2017​.Express Scripts holding-‍enterprise value initiative estimated to cost about $600 million to $650 million ,to deliver cumulative savings of nearly $1.2 billion by 2021​.Express Scripts holding-‍increased its guidance for fy 2017 adjusted earnings per diluted share from a range of $6.95 to $7.05 to a range of $6.97 to $7.05​.Says ‍adjusted earnings per diluted share for q4 of 2017 is estimated to be in range of $2.03 to $2.11​.Express Scripts holding co says ‍expects total adjusted claims for q4 of 2017 to be in range of 347 million to 363 million​.Q4 earnings per share view $2.05 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $6.99 -- Thomson Reuters I/B/E/S.  Full Article

Express scripts to acquire Evicore Healthcare for $3.6 bln
Tuesday, 10 Oct 2017 09:00am EDT 

Oct 10 (Reuters) - Express Scripts Holding Co :Express Scripts to acquire Evicore Healthcare; accelerates company's shift to patient benefit management.Express Scripts Holding Co - deal for ‍$3.6 billion​.Express Scripts Holding Co - ‍expects acquisition to be accretive to adjusted diluted earnings per share in its first full year of operation​.Express Scripts Holding - ‍acquiring Evicore from current investors including General Atlantic, TA Associates, and Ridgemont Equity Partners​.Express Scripts Holding Co says ‍Evicore will operate as a standalone business unit within Express Scripts​.  Full Article

Express Scripts wins dismissal of lawsuit over its dealings with Anthem; plaintiffs can amend complaint
Wednesday, 2 Aug 2017 09:58am EDT 

Aug 2 (Reuters) - Express scripts wins dismissal of shareholder lawsuit over its disclosures about its relationship with anthem antm.n -- u.s. Court ruling issued on aug 1:.  Full Article

Express Scripts says a new contract with Anthem would be "significantly less favorable" to co
Tuesday, 25 Jul 2017 04:49pm EDT 

July 25 (Reuters) - Anthem Inc ::Express Scripts-based on recent statements made,other actions taken by Anthem, co believes unlikely its contract with anthem will be extended‍​.Express Scripts says " if we do enter into new contract with anthem, it would be on terms significantly less favorable to us than current contract".Express Scripts - Anthem contract generated about 19 pct of total consolidated revenues for both three and six months ended june 30, 2017, respectively.  Full Article

Express Scripts Q2 earnings per share $1.37
Tuesday, 25 Jul 2017 04:01pm EDT 

July 25 (Reuters) - Express Scripts Holding Co :Express Scripts announces 2017 second quarter results.Q2 adjusted earnings per share $1.73.Q2 GAAP earnings per share $1.37.Q2 earnings per share view $1.71 -- Thomson Reuters I/B/E/S.Sees Q3 2017 adjusted earnings per share $1.88 to $1.92.Express Scripts Holding Co - increased its guidance for 2017 adjusted earnings per diluted share from a range of $6.90 to $7.04 to a range of $6.95 to $7.05.Express Scripts Holding Co - expects total adjusted claims for Q3 of 2017 to be in range of 340 million to 350 million.Express Scripts Holding Co - adjusted earnings per diluted share for Q3 of 2017 is estimated to be in range of $1.88 to $1.92.Express Scripts Holding Co - qtrly revenues $25,347.5‍​ million versus $25,222.3 million.Express Scripts Holding Co - estimate initiative will deliver savings of approximately $550 million to $600 million annually by 2021.Express scripts holding co qtrly adjusted claims of 350.0 million, flat.Express Scripts Holding Co - company is updating its expected 2018 retention rate for 2017 selling season to be in range of 94% to 96%.Express Scripts Holding Co - company expects to formalize plan for our enterprise value initiative by end of 2017.Express Scripts Holding Co - company's enterprise value initiative is currently estimated to cost approximately $600 million to $650 million.Q3 earnings per share view $1.89 -- Thomson Reuters I/B/E/S.  Full Article

Jazz Pharmaceuticals says on June 28, its unit entered into pharmacy master services agreement with Express Scripts specialty distribution services
Monday, 3 Jul 2017 04:31pm EDT 

July 3 (Reuters) - Jazz Pharmaceuticals Plc ::Jazz Pharmaceuticals says on June 28, its unit entered into a pharmacy master services agreement with express scripts specialty distribution services.Says ‍under master services agreement, jazz is billed monthly for services performed by express scripts.Jazz Pharmaceuticals - pursuant to agreement express scripts provides exclusive distribution and other services to jazz related to sale and marketing of xyrem oral solution in u.s..Jazz Pharmaceuticals plc - master services agreement will expire on June 30, 2019, subject to a one-year extension at option of jazz.  Full Article

BRIEF-Express Scripts' Unit Says Offering Savings on Influenza Medications

* ‍INSIDE RX - OFFERING SAVINGS OF UP TO 25 PERCENT ON BRAND-NAME TAMIFLU, TO OFFER DISCOUNT OF UP TO 28 PERCENT ON GENERICS COMPARED TO RESPECTIVE CASH PRICES Source text for Eikon: Further company coverage: